Hypertension is a familiar chronic disease and an epidemic in recent years, as well as the most important risk factor for cardiovascular and cerebrovascular disease. Many patients always ask questions about the degree of hypertension treatment during outpatient visits. In this article, we will combine the latest hypertension guidelines to specifically introduce the goals of treatment and the degree of treatment for hypertensive patients. I. What is the overall goal of hypertension treatment The fundamental goal of hypertension treatment is to reduce the overall risk of cardiac, renal and vascular complications and death from hypertension. Given that hypertension is a cardiovascular syndrome, i.e., it is often combined with other cardiovascular risk factors, target organ damage, and clinical disease, the timing and intensity of administration of lifestyle improvement and antihypertensive medications should be determined based on the blood pressure level and overall risk level of the hypertensive patient; and the intervention of detected other risk factors, target organ damage, and coexisting clinical disease. Given that the predominance of stroke complications in our hypertensive patients remains fundamentally unchanged, an intensive antihypertensive treatment strategy should be adopted as conditions permit. Second, hypertension should be reduced to what extent Based on evidence from several previous studies, the general patient blood pressure target needs to be controlled to below 140/90 mmHg under tolerable and sustainable conditions, with some of the high-risk patients with diabetes and proteinuria having their blood pressure controlled to below 130/80 mmHg. Although there is also some evidence suggesting higher or lower blood pressure targets in some specific populations, this depends largely on how well the patient tolerates the treatment and how complex it is. If lowering blood pressure to a lower level can be achieved without a complex treatment regimen and is tolerated by the patient, there is no need to change the treatment regimen to bring blood pressure back up. Although some studies have shown that older patients with hypertension have higher blood pressure targets than the general population with hypertension, some recent subgroup analyses of studies have also shown that lower blood pressure targets (SBP <130 mmHg) are beneficial in the older population, and it should be noted that increasing age is not a sufficient condition for setting higher blood pressure targets, and that in older patients, physicians should assess the severity of the patient's comorbidities, treatment tolerability and For elderly patients, physicians should evaluate the severity of the patient's comorbidities, treatment tolerance and possible factors for adherence to treatment to determine the patient's BP target. Based on the above, the choice of treatment regimen and the intensity of application should weigh the long-term benefits and patient tolerability to avoid or minimize discontinuation due to poor patient tolerability. Intensive interventions for high-risk and very high-risk patients and aggressive interventions to reverse target organ damage in patients with subclinical target organ damage without severe comorbidities are justified, but there is a lack of evidence from clinical trials with prognostic endpoints for the administration of antihypertensive medications to people with normal high-value blood pressure at low to moderate risk.